section name header

Information

AHFS Class:

52:40.12 Carbonic Anhydrase Inhibitors


Generic Name

Products

Acetazolamide as the sodium salt is available in 500-mg (unpreserved) vials with sodium hydroxide and, if necessary, hydrochloric acid to adjust the pH.3011; 3030 Each 500-mg vial should be reconstituted with at least 5 mL of sterile water for injection.3011; 3030

pH

Approximately 9.6.3011; 3030

Osmolality

The osmolality of acetazolamide sodium 500 mg was calculated for the following dilutions:1054

Osmolality (mOsm/kg)
Diluent50 mL100 mL
Dextrose 5%321291
Sodium chloride 0.9%348317

Sodium Content

2.049 mEq/500 mg (calculated).846

Administration

Administration by direct intravenous injection is preferred; intramuscular injection is not recommended.3011; 3030

Stability

Intact vials should be stored at controlled room temperature.3011; 3030 Acetazolamide is a white to faintly yellowish white powder.3011; 3030 The manufacturers state that the reconstituted solution is physically and chemically stable for 3 days at 2 to 8°C or for 12 hours at 20 to 25°C; however, storage of the reconstituted solution at 2 to 8°C and use of the solution within 12 hours after reconstitution is recommended.3011; 3030 Any unused portion should be discarded.3011; 3030

pH Effects

The stability of acetazolamide sodium in aqueous solution appears to decrease as the pH increases above 9. At pH 8.8, a 0.25-mg/mL solution retained 96% of the initial amount after 3 days at 25°C; at pH 10.8 and 12.7, 88 and 83% of the concentration, respectively, remained after 4 days.1230 Acetazolamide exhibits maximum stability at pH 4.1424

Sorption

Acetazolamide sodium was shown not to exhibit sorption to PVC bags and tubing, polyethylene tubing, Silastic tubing, and polypropylene syringes.536; 606

Compatibility

Solution Compatibility

Drugs in Syringe Compatibility

Y-Site Injection Compatibility (1:1 Mixture)

Other Info

References

For a list of references cited in the text of this monograph, search the monograph titled References.

Copyrights

ASHP® Injectable Drug InformationTM. Selected Revisions March 31, 2024. © Copyright, 2024. American Society of Health-System Pharmacists®, 4500 East-West Highway, Suite 900, Bethesda, Maryland 20814.